Fractyl Health director granted 22,500 stock options

FRACTYL HEALTH, INC. director Christopher Charles Thompson received a grant of stock options covering 22,500 shares of common stock as compensation for his service on the board under the non-employee director compensation policy.

Rhea-AI Filing Summary

FRACTYL HEALTH, INC. director Christopher Charles Thompson received a grant of stock options covering 22,500 shares of common stock as compensation for his service on the board under the non-employee director compensation policy. The options have an exercise price of $0.7318 per share and expire on June 9, 2036. They vest in a single installment on the earlier of the next annual meeting of stockholders or the first anniversary of the grant, subject to his continued service as a non-employee director. Following this award, he holds 22,500 stock options directly.

Insider Trade Summary

Grant/Award: 22,500 shares

Grant/Award 1 txn

Insider Thompson Christopher Charles

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	22,500	$0.00	$0.00

Holdings After Transaction: Stock Option — 22,500 contracts (Direct)

Footnotes (1)

1. F1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.

Key Figures

Stock options granted: 22,500 options Exercise price: $0.7318 per share Expiration date: June 9, 2036 +2 more

5 metrics

Stock options granted 22,500 options Awarded to director as board compensation

Exercise price $0.7318 per share Strike price for the granted options

Expiration date June 9, 2036 Option term end date

Underlying shares 22,500 shares Common stock covered by the options

Post-grant option holdings 22,500 options Total derivative holdings after this award

Key Terms

Stock Option, non-employee director compensation policy, annual meeting of stockholders, vest and become exercisable

4 terms

Stock Option financial

"The stock option was awarded as compensation for the Reporting Person's service"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

non-employee director compensation policy financial

"pursuant to the Issuer's non-employee director compensation policy"

annual meeting of stockholders financial

"on the earlier of (i) the date of the next annual meeting of stockholders"

vest and become exercisable financial

"The stock option will vest and become exercisable in a single installment"

FAQ

What insider transaction did FRACTYL HEALTH (GUTS) report?

FRACTYL HEALTH reported a stock option grant to director Christopher Charles Thompson for 22,500 shares of common stock. The award was made as compensation for his service on the company’s board under its non-employee director compensation policy.

How many stock options did the FRACTYL HEALTH (GUTS) director receive?

Director Christopher Charles Thompson received stock options for 22,500 shares of FRACTYL HEALTH common stock. These options were granted as board compensation and will vest in a single installment based on future service and the timing of the next annual stockholder meeting.

What is the exercise price of the new FRACTYL HEALTH (GUTS) options?

The granted stock options have an exercise price of $0.7318 per share. This is the price at which the director can buy FRACTYL HEALTH common shares once the options vest and become exercisable, subject to his continued service on the company’s board.

When do the FRACTYL HEALTH (GUTS) director’s stock options vest?

The stock options vest in a single installment on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date. Vesting requires Christopher Charles Thompson to continue serving as a non-employee director through that vesting date.

What is the expiration date of the FRACTYL HEALTH (GUTS) stock options?

The stock options granted to Christopher Charles Thompson expire on June 9, 2036. After this expiration date, any unexercised options will lapse, meaning they can no longer be used to purchase FRACTYL HEALTH common stock at the stated exercise price.

How many FRACTYL HEALTH (GUTS) options does the director hold after this grant?

After this stock option grant, Christopher Charles Thompson holds 22,500 stock options directly. These options relate to FRACTYL HEALTH common stock and reflect his total reported derivative holdings following the compensation award described in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 05:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thompson Christopher Charles

(Last) (First) (Middle)

3 VAN DE GRAAFF DRIVE

SUITE 200

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.7318	06/10/2026		A		22,500		(1)	06/09/2036	Common Stock	22,500	$0	22,500	D

Explanation of Responses:

1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.

	/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)